That's important, because the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be effective. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental process (jeff bezos). Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're developed to do. This was an advancement practically no one noticed. But it's going to have extensive ramifications for curing illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be lots of financial investment chances in this area, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (brownstone research stock). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps substantially prior to going greater - brownstone research. I have actually been covering bitcoin for a long period of time now. Among the very first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were primarily educating readers. However that's not the huge concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown stock market prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of excellent personal business on the verge of hitting the public markets And I've been dealing with a brand-new method for you to invest even prior to these companies go public.
This opportunity has actually been developing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to book your spot totally free.
Emma Walsh here, handling editor of the Diary. Routine Diary readers understand that tech isn't our usual beat (exponential growth). And when it pertains to tech investing, we leave it to the professionals. Luckily, we have numerous such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing professionals we know (jeff brown 1 biotech). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big picture and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These patterns are experiencing exponential development and producing incredible opportunities for investors. I desire to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown. But in spite of what lots of readers may think, this is a trend that's just beginning. Despite the fact that the COVID-19 pandemic interrupted supply chains last year, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (tech predictions). Losing 2 months of production and sales actually impacts the number of 5G devices are sold in the calendar year. When you consider all of that, offering 250 million units is remarkable. More significantly, the delays triggered by the pandemic developed a lots of bottled-up need. Which need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G gadgets will be shipped in 2021 - bleeding edge. And that's not my only 5G forecast When I've talked about 5G in the past, I have actually explained its three various phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Phase 3, 5G services begin to be provided (future report). That's when we start to see applications working on 5G networks. Consider things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase 3 by this summertime. This starts something of a virtuous cycle: The majority of people do not truly care about the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open up a suite of unbelievable applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities going forward will be enormous. Stepping far from 5G, the next important technology I foresee in 2021 is CRISPR hereditary editing. CRISPR means "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it is among the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For many years, CRISPR was mostly a niche innovation that wasn't well understood. And throughout that time, there were truly only 3 companies operating in this area. But things are altering. CRISPR is no longer simply theoretical. We're seeing actual results. We're dealing with diseases and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and providing incredible returns. This whole market is successfully a greenfield opportunity.
There's room for many business to exist in this space. angel investor. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or three more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software application can accurately predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is necessary due to the fact that the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has actually been a trial-and-error procedure. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but several drug treatments produced using this technology. This was one of those developments that nearly no one observed. However it's going to have profound implications for curing illness. And, of course, there will be lots of investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe substantially prior to going higher. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever published was on bitcoin - exponential growth. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. But at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. white house. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the info depends on date as of February 2021, however we could not individually confirm this claim. Given Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an exact figure at this minute. Brown is best known for his sage-like capability to choose winning technology stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent viewpoint on the market. He's constantly on the hunt for new chances, and he shares much of his finest picks in the Near Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he successfully anticipated a few of the biggest economic events of the past 20 years. Although he does not appear to launch his picks to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal every time, however Jeff Brown's precise predictions have actually made him legions of dedicated followers. That states a lot about his ability. The Future Report is released by Brownstone Research, a popular monetary research study publisher. Brownstone Research study provides several research study services with a wide range of specializations - tech predictions.
The company is also connected with Bonner & Partners, another well-respected research study publisher - jeff bezos. On its website, Brownstone says its objective is to provide retail financiers with professional-grade research study: "For too long, the best investment research has not been available to individual investors. It has been generally booked for investment banks, hedge funds, personal equity, and high-net-worth clients. exponential growth. The mission of Brownstone Research is to make that sort of exclusive research readily available to any investors seeking to get an edge in the markets. The objective is basic to deliver unique and successful financial investment research found nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also acts as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After years of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you understand even a bit about the market, you understand that he has a reputation as a King Midas of sorts. exponential growth. Whatever he touches relies on gold! Jeff is well conscious of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown believes S.A.V. jeff brown prediction. could be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying two innovative technologies: synthetic intelligence and electric cars and trucks. Musk hopes the combination will help him develop the first fully-autonomous, self-driving cars ever. It's nothing except the automobile industry's Holy Grail. As you know, electric automobiles and self-driving car stocks have actually been big this year, however the Wall Street maker has actually been huge on buzz without much tangible outcome. Regardless of an extreme increase in competition over the past few years, Brown still thinks Musk has the finest opportunity of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Lorry, and it could be the future of transportation. Generally, this technology would permit you to lease out your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the car and press a button on an app that tells the cars and truck to "join the fleet." Next thing you understand, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the revenues. It sounds insane, but it could be closed than you believe.